Phase III BLOCKSTONE study of Xofluza to prevent influenza infection meets primary endpoint June 4, 2019
Kyowa Hakko Kirin initiates Japanese phase III trial of brodalumab in systemic sclerosis June 4, 2019
Conditional European marketing authorization for Zynteglo for transfusion-dependent beta-thalassemia June 4, 2019
RSS